The study involving AuNPs modified with trastuzumab (spherical 30 nm, i.t.)confirmed the regression of tumor size (54), the same effect described was with nanoclusters with anti-RhoJ antibody (16.3 nm, i.v.)(74). Here, RHOJ is linked to neoplasm.